Target intelligence / Profile preview

Mycobacterial membrane phospholipids

Molecular classification
Lipid, Phospholipid, Other
01

Overview

Mycobacterial membrane phospholipids are essential structural components of the complex cell envelope of Mycobacterium species, such as Mycobacterium tuberculosis. These lipids, including phosphatidylinositol mannosides (PIMs), phosphatidylethanolamine (PE), and cardiolipin (CL), are critical for maintaining the structural integrity and the extreme impermeability of the mycobacterial cell wall (Jackson, M., 2014, Cold Spring Harb Perspect Med). They serve as the foundation for the plasma membrane and the inner leaflet of the outer mycomembrane, acting as a barrier against host immune responses and antibiotic penetration (Chiaradia, L., et al., 2017, Future Microbiol). Beyond their structural role, phospholipids like PIMs are precursors to major immunomodulatory lipoglycans such as lipoarabinomannan (LAM), which are vital for host-pathogen interactions and the modulation of the host immune system (Morita, Y. S., et al., 2011, Crit Rev Biochem Mol Biol). In disease states like tuberculosis, these phospholipids facilitate the survival of the bacteria within host macrophages by preventing phagosome-lysosome fusion. Therapeutic strategies targeting these phospholipids often involve direct membrane disruption or the inhibition of their biosynthetic pathways, as seen with drugs like clofazimine or experimental antimicrobial peptides (Pal, R., et al., 2021, ACS Infect Dis). However, the similarity between certain bacterial and host phospholipids presents a significant challenge for achieving high selectivity and minimizing systemic toxicity in human patients.

Other names
Mycobacterial lipidsCell wall phospholipidsPhosphatidylinositol mannosidesPIMsMycobacterial membrane lipidsPhosphatidyl-myo-inositol mannosides
02

Mechanism of action

Direct disruption of membrane integrity, depolarization of the lipid bilayer, and inhibition of the biosynthesis of essential cell wall components such as lipoarabinomannan.

03

Biological functions

Immune responseCell wall integrityPermeability barrierHost-pathogen interactionOther
04

Disease associations

Infection
05

Safety considerations

Selectivity issues between bacterial and host membranesHemolysisNephrotoxicitySystemic toxicity
06

Interacting drugs

Clofazimine

4 more in the full profile.

07

Biomarkers

Lipoarabinomannan (LAM)Phosphatidylinositol mannosides (PIMs)

Beyond the preview

Go deeper on Mycobacterial membrane phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial membrane phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call